Publications of A. Schuld
All genres
Journal Article (63)
1.
Journal Article
135 (1-3), pp. 123 - 127 (2012)
Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research 2.
Journal Article
35 (2), pp. 231 - 236 (2012)
Glucose Tolerance in Patients with Narcolepsy. Sleep 3.
Journal Article
27 (Suppl. 1), 0-27 (2012)
Sleep propensity at daytime as assessed by multiple sleep latency tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. European Psychiatry 4.
Journal Article
45 (9), pp. 1223 - 1228 (2011)
The stress hormone system in various sleep disorders. Journal of Psychiatric Research 5.
Journal Article
34 (1), pp. 118 - 128 (2009)
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 6.
Journal Article
27 (6), pp. 662 - 666 (2007)
Clozapine and olanzapine are associated with food craving and binge eating - Results from a randomized double-blind study. Journal of Clinical Psychopharmacology 7.
Journal Article
40 (5), p. 241 - 241 (2007)
Daytime sleep after glucose intake in patients with narcolepsy. Pharmacopsychiatry 8.
Journal Article
2, pp. 293 - 302 (2007)
Immunoendocrine abnormalities in narcolepsy. Sleep Medicine Clinics 9.
Journal Article
60, pp. 882 - 888 (2006)
Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA axis. Biological Psychiatry 10.
Journal Article
29 (1), p. 170 - 170 (2006)
Changes in weight and glucose tolerance during treatment with mirtazapine. Diabetes Care 11.
Journal Article
114, pp. 322 - 328 (2006)
Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Experimental and Clinical Endocrinology & Diabetes 12.
Journal Article
38 (5), p. 230 - 230 (2005)
Impaired glucose tolerance in patients with narcolepsy. Pharmacopsychiatry 13.
Journal Article
38 (5), p. 249 - 249 (2005)
Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Pharmacopsychiatry 14.
Journal Article
38 (5), pp. 248 - 249 (2005)
Does antidepressant therapy improve glucose metabolism? Pharmacopsychiatry 15.
Journal Article
38 (5), p. 264 - 264 (2005)
Efficacy of electroconvulsive therapy for depressive disorders in a Bavarian district hospital. Pharmacopsychiatry 16.
Journal Article
38 (5), p. 270 - 270 (2005)
Cognitive-behavioral therapy of patients with pure and comorbid panic disorder in a hospital setting - a comparison of therapy response. Pharmacopsychiatry 17.
Journal Article
38 (5), p. 270 - 270 (2005)
Metabolic abnormalities in patients with chronic psychiatric disorders receiving long-term psychopharmacological treatment. Pharmacopsychiatry 18.
Journal Article
102 (31-32), pp. A 2172 - A 2177 (2005)
Gewichtszunahme unter Psychopharmakotherapie. Deutsches Ärzteblatt 19.
Journal Article
39, pp. 35 - 42 (2005)
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain. Journal of Psychiatric Research 20.
Journal Article
179 (2), pp. 447 - 451 (2005)
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology